"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
The following local adverse
reactions are reported infrequently with topical corticosteroids, but may
occur more frequently with the use of occlusive dressings.These reactions are
listed in an approximate decreasing order of occurrence:
Allergic contact dermatitis
Maceration of the skin
Read the Synalar (fluocinolone acetonide) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 12/10/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Synalar Information
Synalar - User Reviews
Synalar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.